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Abstract 
Purpose: To investigate the knowledge and attitude of outpatients regarding pharmaceutical package 
inserts (PPIs) in Karachi, Pakistan.  
Methods: The study design was cross-sectional and conducted from August to December 2013. A 
previously validated questionnaire was adopted, modified and revalidated. Outpatients were asked to 
respond to the questionnaire. 
Results: A total of 456 patients responded to the questionnaire. The patients (n = 226, 49 %) were 
found to be keen on reading inserts in their mother language. Among the study population, 24.1 % (n = 
110) of respondents faced problem in reading and 29.8 % (n = 136) in understanding inserts. There was 
general awareness of the essential components of package inserts and 78.3 % (n = 357) of patients 
opted for further improvement in PPIs of drugs available in Pakistan. Chi square test revealed that 
educational status of patients was significantly associated with all of the items of the questionnaire (p < 
0.05). 
Conclusion: The current status of PPIs of drugs available in local markets in Pakistan does not satisfy 
the patients’ criteria and, therefore, needs improvement. The findings of this study provide a direction 
necessary to overcome problems related to PPIs and hence promote safe and effective use of 
medicines. 
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Safety and efficacy of medicines accompanied 
with accurate and reliable drug product 
information. Pharmaceutical companies adopt 
various scientific ways to provide information 
including verbal communication through medical 
representatives, scientific meetings as well as 
written material (periodical, promotional 
materials, pharmaceutical packaging insert). 
Printed information accompanying drug products 
includes the information on the primary or 
immediate drug packaging, the external package 
as well as the inserts or leaflets [1].  
 
The pharmaceutical package insert (PPI) is an 
important tool for providing essential drug 
information to patients taking over-the-counter 
(OTC) medicines. Studies have shown that the 
PPI helps to bridge the information gap between 
health care providers and patients and also 
boosts the level of patients’ knowledge about 
medications [2]. It is very important that the 
information written on PPI should strictly follow 
the criteria as that it should be comprehensive, 
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up to date, clear and legible for patients and care 
givers in case of OTC drugs.  
 
The quality and quantity of information available 
in the PPI plays important role for influential 
patients’ compliance and satisfaction [3]. The 
studies showed that patients who read the PPI 
are more likely to follow the instructions [4]. 
Despite the fact that physicians and pharmacists 
are the preferred sources of information, 
healthcare professionals do not always ensure 
optimal knowledge transfer [5]. In addition, 
information given verbally may likely be either 
misunderstood or forgotten that is why a paper 
label is given [6]. Researchers also revealed that 
medication error and poor patient compliance 
may be the consequences of problem in reading 
and understanding of PPI by patients [7-9].  
 
It is imperative to know the perception of 
patients/consumers about PPI. Such type of 
information has not been reported from Pakistan 
yet. Although some studies regarding the 
detailed analysis of such PPIs was done [10,11]. 
The present study was aimed to determine the 
attitude and perception of the outpatients 
towards PPIs of pharmaceutical product 




Study design and setting 
 
A questionnaire-based cross-sectional study was 
conducted over 5-month period (August to 
December 2013) in two out-patient department of 
one public and one private sector tertiary care 
hospitals of Karachi. Previously validated 
questionnaire was adopted and modified [12,13]. 
Internal reliability score was checked by applying 
cronbach’s alpha. Patients attending outpatient 
clinics constituted the study population and 
asked to fill the questionnaire. The sample size 
was calculated by Open Epi® online software 
and non probability sampling technique was 
adopted.  
 
There was no earlier estimation regarding the 
knowledge of PPIs in Pakistan. Therefore, it was 
assumed that the prevalence of knowledge was 
50 % and calculated the required sample for our 
survey with an allowable error of 5 % and 95 % 
confidence limits. Altogether, 456 respondents 
participated in the study. Written consents were 
taken and participation in the study was 
anonymous. Demographic data of respondents 





Data was entered in Statistical Package for 
Social Sciences (SPSS 20.0, Chicago, IL). 
Descriptive statistics on characteristics of 
respondents were calculated. Response was 
calculated as number and frequency of YES or 
NO. Bivariate analysis was applied using Chi 
square test to observe the association of age and 





The study was conducted after taking approval 
from the director/head of outpatient department 
of tertiary care hospitals. Demographics and 
responses of the patients collected during the 
present study were kept confidential and only 
being used for this research paper. Patients were 
briefed about the purpose of the study prior to 




The present plan comprising of questionnaire 
based study was executed to be acquainted with 
the perception of outpatients of Karachi about 
PPI. The adopted questionnaire was revalidated 
and cronbach’s alpha of 15 items was 0.730. 
Four hundred and fifty six respondents 
participated in the study (an overall response 
rate was 82.9 %). The study population 
comprised of uneducated (n = 26, 5.7 %), O & A 
grade (n = 112, 24.5 %) and graduated patients 
(n = 318, 69.8 %). Majority of the respondents 
were below the age of 30 years (n = 284, 62.3 
%)  
 
The study outcomes revealed that 22.8 % (n = 
104) of patients do not read PPIs before using 
the medications. Respondents also had 
problems in reading (n = 110, 24.1 %) and 
understanding (n = 136, 29.8 %) of PPI. The 
patients (n = 226, 49.6 %) were found to be keen 
in reading inserts in their mother language. 
Approximately 84 % (n = 383) emphasized that 
the information regarding dose, direction and 
duration of use, side effects, precautions and 
interactions were useful parts of PPIs of OTC 
medicines. A majority of respondents (n = 357, 
78.3 %) thought that the PPIs of products 
marketed in Pakistan need improvement to meet 
the international standards (Table 1). 
 
Statistical analysis (Chi square test) disclosed 
that educational status of patients was 
significantly associated with all of the items of 
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questionnaire (p < 0.05), however age of the 
patients was significantly associated (p < 0.001) 
with some of the responses i.e. easy to 
understand PPI, a toll free number in the 





PPIs have influential role of providing essential 
medical information to improve patient 
compliance and minimize medication errors. 
Effective designing of PPIs should be focused on 
the literacy level of patients. Furthermore, 
presenting information in mother language of 
patient improves patient comprehension. This is 
very crucial regarding OTC medicines used by 
general public. A study conducted in Turkey said 
that 78.2 % of patients read PPIs [8]. In 
Germany, a study revealed that only 54.8 % of 
patients read PPIs always before using new 
medications [14]. However, in UK only 35 % of 
patient reads PPI completely [9]. Another 
researcher reported that 49.2 % patients always 
read PPI and 48.3 % of patients said that they 
faced problem in understanding PPIs [15]. As 
majority of the respondents were educated, they 
were aware of the significance of reading PPI. A 
small proportion of respondents faced problems 
in reading and understanding PPIs (Table 1).  
 
The information on PPIs should preferably be in 
the mother language for improved patient 
compliance. Otherwise, it will be very hard to 
understand PPIs by general population. A large 
number of respondents prefer to read PPIs in 
both languages, i.e., English and their mother 
language. However, half of the respondents 
wished to read these PPIs in their mother 
language i.e. Urdu. Palestine consumers of 
medications were also found willing to have PPIs 
in Arabic [16]. Medication error and adverse 
effects were observed in patients with limited 
literacy including misuse of drug and multiple 
medication regimens [7]. The reasons may 
include misunderstanding of PPIs leading to 
treatment failure which can be overcome by 
designing PPI in mother language. 
 
PPI includes information regarding active drug 
ingredient, indication and contraindication. 
Majority of respondents opinioned positively to 
have these information on PPI. General public of 
Saudi Arabia emphasized on the importance of 
indications and adverse drug reactions 
mentioned on PPIs [17]. FDA published 
guidelines for the consumer medication 
information in written form emphasize on the 
basic information written on the PPIs including 
some other consideration. These include certain 
general information, including encouraging 
patients to communicate with healthcare 
professionals and disclaimer statements; 
information that is scientifically accurate, 
unbiased and up-to-date and information in an 
understandable and legible format that is readily 
comprehensible to consumer [18]. 
 
Table 1: Outpatients’ response to the 15-item questionnaire 
 
Question Yes No 
N (%) N (%) 
Do you read package insert? 352(77.2) 104 (22.8) 
Do you read expiry date before using the medication? 418 (91.7) 38 (8.3) 
Do you store the medication at the temperature specified in the package insert?  342 (75) 114 (25) 
Do you prefer to read package insert in English?  334 (72.2) 122 (28.8) 
Do you prefer to read package insert in Urdu?  226 (49.6) 230 (50.4) 
Do you prefer to read package insert in both English and Urdu?  299 (65.6) 157 (34.4) 
Do you think that written information of package insert is easy to read? 346 (75.9) 110 (24.1) 
Do you think that written information of package insert is easy to understand? 320 (70.2) 136 (29.8) 
Do you think that a toll free number in the package insert to give any required drug 
information can be useful? 
312 (68.4) 144 (31.6) 
Do you think that information on package insert should be improved in our country? 357 (78.3) 99 (21.7) 
Do you think that Active ingredient, clinical indication and contraindications are 
useful part of package insert for you? 
370 (81.1) 86 (18.9) 
Do you think that dosage instructions and direction for use are useful part of 
package insert for you? 
383 (84) 73 (16) 
Do you think that side effects, precautions and interactions are useful part of 
package insert for you? 
386 (84.6) 70 (15.3) 
Do you think that manufacturers’ information is useful part of package insert for 
you? 
318 (69.7) 138 (30.3) 
Do you think that package insert of multi-national companies are better than local 
companies? 
352 (77.2) 104 (22.8) 
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It was very encouraging that the patients, who 
were educated, had knowledge of gold standards 
for PPIs.  
 
Many studies reported a link between reading, 
understanding the PPIs and patient 
characteristics including literacy, health status, 
occupation and age [19, 20]. Bivariate analysis 
using chi-square test was applied to observe the 
association of age and educational status of 
patients with their response. Educational status 
of the respondents was significantly associated 
with their response to all of questions (p < 0.05). 
Age of the patients was also significantly 
associated (p < 0.001) with some of the 
responses i.e. easy to understand PPI, a toll free 
number in the package insert and manufacturer 
information is useful. Other researchers also 
observed such type of association [7].  
 
The study results showed that PPIs should be 
improved in terms of readability and 
understanding keeping in view the patient 
demographics especially literacy level and age 
group. It is a general perception of our 
community that multinational companies are 
much better than local companies. In this 
continuation a question was asked regarding the 
comparison of package inserts of multinational 
companies with local companies? Majority of 
patients answered in ‘Yes’ (Table 1). They also 
drew the attention towards the need for 
improvement PPIs of products marketed in 
Pakistan. Ministry of Health is also responsible to 
regulate PPIs by implementing the standard rules 
to communicate properly all the information to 
the patients as well as to the health care 
professional irrespective of the type of 
manufacture.  
 
Limitation of the study 
 
The first limitation is that the sample size used 
was small. Secondly, patients with little or no 
literacy level were in a minority. The present 
survey was conducted among outpatients in 
Karachi and, therefore, the results should not be 




The objective of catching the perception of 
outpatients’ about PPI was accomplished. It 
revealed that the information written on PPI of 
drugs available in local market of Pakistan was 
readable and understandable for the literate 
patients. They were not observed fully satisfied 
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